Terms: = Lymphoma AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Clinical Outcome
6 results:
1. Characterizing kinase intergenic-breakpoint rearrangements in a large-scale lung cancer population and real-world clinical outcomes.
Yao Y; Yu Z; Ma Y; Ou Q; Wu X; Lu D; Li X
ESMO Open; 2022 Apr; 7(2):100405. PubMed ID: 35305401
[TBL] [Abstract] [Full Text] [Related]
2. clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases.
Kuang M; Shen X; Yuan C; Hu H; Zhang Y; Pan Y; Cheng C; Zheng D; Cheng L; Zhao Y; Tao X; Li Y; Chen H; Sun Y
Am J Clin Pathol; 2018 May; 150(1):65-73. PubMed ID: 29746612
[TBL] [Abstract] [Full Text] [Related]
3. An unexpected role for caspase-2 in neuroblastoma.
Dorstyn L; Puccini J; Nikolic A; Shalini S; Wilson CH; Norris MD; Haber M; Kumar S
Cell Death Dis; 2014 Aug; 5(8):e1383. PubMed ID: 25144718
[TBL] [Abstract] [Full Text] [Related]
4. VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms.
Roorda BD; Ter Elst A; Scherpen FJ; Meeuwsen-de Boer TG; Kamps WA; de Bont ES
Eur J Cancer; 2010 Mar; 46(5):974-82. PubMed ID: 20064707
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients.
Chevallier P; Robillard N; Wuilleme-Toumi S; Méchinaud F; Harousseau JL; Avet-Loiseau H
Haematologica; 2004 Nov; 89(11):1399-401. PubMed ID: 15531467
[TBL] [Abstract] [Full Text] [Related]
6. Lack of her-2/neu expression in Hodgkin and non-Hodgkin lymphoma.
Bairey O; Pazgal I; Okon E; Shaklai M; Morgenshtern S
Arch Pathol Lab Med; 2002 May; 126(5):574-6. PubMed ID: 11958663
[TBL] [Abstract] [Full Text] [Related]
